Madhuri Singh

About

Currently, I am engaged in understanding the genetic basis of vancomycin resistance in staphylococcus aureus, and adaptation of MSSA to vancomycin in vitro conditions. previously, I had been working on antimicrobial peptides, novel anti bacterial agents and herbal therapies to treat MRSA. A full proof solution against MRSA/VRSA is yet to be invented. Therefore, I am striving to seek a solution against multi drug resistance.

Employment

• Juntendo Daigaku Postdoctoral Fellow
  2014 - Present

Education

• Jawaharlal Nehru University PhD
  2008 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Detection of Multidrug-Resistant Acinetobacter Junii in a Himalayan Freshwater Ecosystem: A Pilot Study from Kumaon Kosi River
  Current World Environment 2026 DOI: 10.12944/CWE.21.1.8
  +Save
• Prevalence and antibiogram of coagulase negative Staphylococci in bioaerosols from different indoors of a university in India
  BMC Microbiology 2020 DOI: 10.1186/s12866-020-01875-8
  +Save
• RNA Sequencing Identifies a Common Physiology in Vancomycin- and Ciprofloxacin-Tolerant Staphylococcus aureus Induced by ileS Mutations
  Antimicrobial Agents and Chemotherapy 2020 DOI: 10.1128/AAC.00827-20
  +Save
• Combination of Alpha-Melanocyte Stimulating Hormone with Conventional Antibiotics against Methicillin Resistant Staphylococcus aureus
  2013 DOI: 10.1371/journal.pone.0073815
  +Save
• Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides
  2013 DOI: 10.1128/AAC.00780-13
  +Save
• Characterization of cell membrane parameters of clinical isolates of Staphylococcus aureus with varied susceptibility to alpha-melanocyte stimulating hormone
  2012 DOI: 10.1016/j.peptides.2012.05.025
  +Save
• C-terminal amino acids of alpha-melanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus
  2011 DOI: 10.1128/AAC.00957-10
  +Save